Stock Taper
TTRX
TURN THERAPEUTICS INC.
NASDAQ
$9.84
▼ DOWN 2.67% (-0.27)

KEY STATISTICS

Market Cap$293.11 M
52w High$26.50
52w Low$2.57
Dividend Yield
Frequency
P/E-33.87
Volume62.76K
Shares Out.29.79M

COMPANY

LEADERSHIP

Bradley E. Burnam
CHIEF EXECUTIVE
Bradley E. Burnam

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 8, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
2

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.
NOV
12
THU

PRICE

$9.84 ▼ DOWN 2.67% (−$0.27)
$9.60$9.90$10.209:37 AM10:41 AM11:44 AM12:48 PM1:52 PM2:55 PM3:59 PM9.84

About Turn Therapeutics Inc.

https://www.turntherapeutics.com ↗

Global Health Solutions, Inc. (Turn Therapeutics) develops skin, nail, and eye drugs using advanced delivery tech to treat wounds and skin conditions while reducing antibiotic resistance, based in Westlake Village, CA since 2015.

INDUSTRY

Biotechnology

A PRODUCT TURN THERAPEUTICS INC. IS KNOWN FOR

GX-03
GX-03

Turn Therapeutics' primary focus is a Phase 2 non-steroidal topical treatment for moderate-to-severe atopic dermatitis, utilizing proprietary PermaFusion® technology to modulate skin immune response.

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
AGEN$7.66COMPARE
IKT$2.41COMPARE
IRD$3.69COMPARE
GLSI$15.67COMPARE
HURA$2.11COMPARE
ANIX$3.48COMPARE
SEER$1.98COMPARE
CGTX$1.02COMPARE